Note from GMOScience: The following has been submitted by Third World Network (https://twn.my)
US rDNA Committee Disbanded, Exacerbating Poor Oversight of GE Research
Few outside the world of science policy noticed late last year when the US Recombinant DNA Advisory Committee, in operation since 1975, formally ceased to exist. It was a surprising fate for a group that, some argue, was the single most influential in the global (non-)regulation of genetic engineering research risks. What does this mean for biosafety in the US and elsewhere? The crumbling of the US’ national genetic engineering safety net, which was never very robust to begin with, leaves yawning gaps in US biotechnology oversight, even as a raft of new and potentially dangerous technologies, such as gene editing and synthesis, become broadly accessible, and even as the US still holds itself out as some sort of biotechnology regulation model for the world.
The TWN Biosafety Briefing, ‘The quiet death of the Recombinant DNA Advisory Committee (RAC)’, suggests steps for rectifying the numerous problems. These recommendations are also relevant and have potential applicability elsewhere, both nationally and internationally. The Briefing is available here: https://wp.twnnews.net/wp-content/uploads/2020/09/Biosafety-Briefing_RAC.pdf.
Why Study Toxic Metals in Infant Formula? An Overview of the Results
Why Study Toxic Metals in Infant Formula?
An Overview of the Results
May 2024
Michelle Perro, MD
CEO, GMOScience.org
Article 3 in the Got Real Milk Series
The presence of toxic metals in infant formula is a critical issue that demands immediate action.
Public education is crucial to raise awareness among parents and caregivers about the potential risks and safety measures. Regulatory action by Congress is necessary to empower the FDA and other agencies to enforce stringent safety standards. Additionally, formula companies must take corrective actions to ensure their products are safe.
To address this issue, we are initiating a petition to urge Congress to remove any barriers preventing the FDA from enforcing these necessary regulations. In the meantime, parents can consider various supplements that may help offset the toxicity, although this should be done in consultation with healthcare professionals.
By working together—regulators, companies, and consumers—we can ensure that infant formula products are safe and healthy for our most vulnerable population, our babies.
